Lyka Labs Ltd LYKALABS-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 3:10 PM IST
141.25quote price arrow up+6.70 (+4.98%)
Volume
6,595
52 week range
47.05 - 267.00
Loading...
  • Open141.25
  • Day High141.25
  • Day Low141.25
  • Prev Close134.55
  • 52 Week High267.00
  • 52 Week High Date12/24/21
  • 52 Week Low47.05
  • 52 Week Low Date05/17/21

Key Stats

  • Market Cap47.47M
  • Shares Out28.69M
  • 10 Day Average Volume113,605.78
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-36.37

KEY STATS

  • Open141.25
  • Day High141.25
  • Day Low141.25
  • Prev Close134.55
  • 52 Week High267.00
  • 52 Week High Date12/24/21
  • 52 Week Low47.05
  • 52 Week Low Date05/17/21
  • Market Cap47.47M
  • Shares Out28.69M
  • 10 Day Average Volume113,605.78
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-36.37

RATIOS/PROFITABILITY

  • EPS (TTM)19.21
  • P/E (TTM)7.35
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date08/14/1996
  • Div Amount2.50
  • Split Date-
  • Split Factor-

Latest On Lyka Labs Ltd

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Lyka Labs Limited is an India-based company that is engaged in the business of pharmaceutical and related activities, including research. The Company is focused on the manufacturing of pharmaceutical formulations and active pharmaceutical ingredients (APIs) across various therapeutic segments. It has developed various products in the product categories, such as injectables, including liquid injections, lyophilized injections in antibacterial, antifungal, NSAIDS, proton pump...
Kunal Gandhi
Chief Executive Officer, Joint Managing Director
Yogesh Shah
Chief Financial Officer, Additional Executive Director
Address
101 - Shiv Shakti Industrial Estate
Andheri Kurla Road, Andheri (East)
Mumbai
400036
India